Screener
Eton Pharmaceuticals, Inc. ETON Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 372 | 326 |
| Intangible assets, net | 43,738 | 30,878 |
| Operating lease right-of-use assets, net | 301 | 310 |
| Other long-term assets, net | 54 | 19 |
| Total assets | $97,710 | $92,114 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $13,485 | $10,976 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s other non-current assets?
- Eton Pharmaceuticals, Inc. (ETON) reported other non-current assets of $54K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
- Eton Pharmaceuticals, Inc.'s other non-current assets increased by 350.0% year-over-year, from $12K to $54K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s other non-current assets has grown at a -13.8% compound annual growth rate (CAGR), from $40K to $19K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Eton Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude